A5073016299- Cutaneous Melanoma Detection and Management
- Nonmelanoma Skin Cancer Studies
- AI in cancer detection
- Transgenic Plants and Applications
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Toxin Mechanisms and Immunotoxins
- Monoclonal and Polyclonal Antibodies Research
Charité - Universitätsmedizin Berlin
2020-2021
e19015 Background: CY-503 is a recombinant mistletoe lectin ( INN: aviscumine) leading to catalytical inactivation of ribosomes, thereby inhibiting protein synthesis. Dependent on dosage immunomodulatory and cytotoxic effects are induced. In patients (pts.) with stage IV metastatic melanoma could potentially lead an antitumoral response. Methods: Pts. (ECOG performance score 0-1), who had failed from one or more previous systemic chemotherapies, were eligible in this trial. severe organ...
<sec> <title>BACKGROUND</title> Recent years have been witnessing a substantial improvement in the accuracy of skin cancer classification using convolutional neural networks (CNNs). CNNs perform on par with or better than dermatologists respect to tasks single images. However, clinical practice, also use other patient data beyond visual aspects present digitized image, further increasing their diagnostic accuracy. Several pilot studies recently investigated effects integrating different...